American Academy of Dermatology

AMERICAN ACADEMY OF DERMATOLOGY: HOW CLIMATE CHANGE AND WILDFIRE SMOKE CAN IMPACT THE SKIN

Retrieved on: 
Friday, March 17, 2023
Flare, Skin, University, Dermatitis, Wildfire, University of California, San Francisco, Psoriasis, Quality of life, American Academy, Fire, Atopic dermatitis, Cell, Doctor of Philosophy, FAAD, Pollutant, Dermatology, MD, Patient, Annual general meeting, American Academy of Dermatology, Health, Air pollution, Sulfur, Nursing

NEW ORLEANS, March 17, 2023 /PRNewswire/ -- New research1,2,3 shows that as wildfires are increasing in frequency, intensity and extent, and affecting air quality across the U.S., they are having a detrimental effect on people with and without skin conditions. A board-certified dermatologist at the American Academy of Dermatology's Annual Meeting in New Orleans will discuss strategies to minimize the effect air pollution can have on your skin.

Key Points: 
  • A board-certified dermatologist at the American Academy of Dermatology's Annual Meeting in New Orleans will discuss strategies to minimize the effect air pollution can have on your skin.
  • Psoriasis occurs when the body makes skin cells too quickly, causing the cells to pile up and form visible patches or spots on the skin.
  • Dr. Wei noted there are no studies that have confirmed how to minimize the effects of wildfire air pollution on skin conditions like psoriasis and eczema.
  • If you have a skin concern, you should partner with a board-certified dermatologist, said Dr. Wei.

AMERICAN ACADEMY OF DERMATOLOGY: COULD A METAL IMPLANT AFFECT YOUR SKIN?

Retrieved on: 
Friday, March 17, 2023
Infection, Allergy, Metal, Stanford School, Allergic contact dermatitis, American Academy, Temperature, Inflammation, History, FAAD, Rash, Pain, Stanford University School of Medicine, Dermatology, MD, Patient, Nickel, Immune system, Irritation, Annual general meeting, Blister, American Academy of Dermatology, Dry, Allergen, Skin, Birth control, Medical device, Dentistry

NEW ORLEANS, March 17, 2023 /PRNewswire/ -- Millions of people in the U.S. report having a metal allergy, and current estimates state that 10 percent of Americans will receive a medical implant during their lifetime1. Board-certified dermatologists attending the American Academy of Dermatology's Annual Meeting in New Orleans are seeing more patients concerned about a possible skin hypersensitivity to the nickel or other metals used in implanted medical devices. 

Key Points: 
  • "For example, if it's an orthopedic implant, there are ceramic options, which won't affect those who have a metal allergy.
  • Often, when a metal implant is put into the body, it releases some amount of metal for a certain period of time, which can cause irritation in people who have metal allergies.
  • If the issue doesn't resolve, other options — such as removal of the implant — may be considered on a case-by-case basis.
  • "A dermatologist can work with you and your surgeon to determine the best course of action based on your symptoms."

AMERICAN ACADEMY OF DERMATOLOGY: RESEARCH SUGGESTS CONNECTION BETWEEN HAIR LOSS IN WOMEN AND OTHER DISEASES

Retrieved on: 
Friday, March 17, 2023
Dandruff, Hair, Diabetes, Minoxidil, Hair loss, Heredity, Quality of life, Scar, Woman, Acne, Tenderness, American Academy, Research, FAAD, Scalp, Hormone, Howard University College of Medicine, Pain, Dermatology, Traction, MD, Patient, Annual general meeting, Menopause, CCCA, Diagnosis, American Academy of Dermatology, Female, Breast cancer, Disease, Cosmetics, Black

NEW ORLEANS, March 17, 2023 /PRNewswire/ -- Hair loss in women can be emotionally devastating and may negatively impact quality of life, and new research suggests that it can also be associated with having other common medical conditions. A board-certified dermatologist at the American Academy of Dermatology's Annual Meeting in New Orleans will discuss the types of hair loss seen in women with darker skin tones, common types of medical conditions associated with hair loss, and hair loss treatment options. 

Key Points: 
  • A board-certified dermatologist at the American Academy of Dermatology's Annual Meeting in New Orleans will discuss the types of hair loss seen in women with darker skin tones, common types of medical conditions associated with hair loss, and hair loss treatment options.
  • While it's possible to regrow some hair, once the hair follicle scars completely, regrowing hair becomes difficult and hair loss can be permanent.
  • Another common type of hair loss is female pattern hair loss, which affects millions of women of all skin tones.
  • Minoxidil is a common treatment option for female pattern hair loss because it has been shown to reduce hair loss, stimulate hair growth, and strengthen existing strands of hair.

American Academy of Dermatology installs new officers, board members

Retrieved on: 
Friday, March 17, 2023
Florida State University College of Medicine, Hair, Cleveland Clinic, Osteopathic medicine in the United States, Health policy, University, College, Edward Via College of Osteopathic Medicine, Wake Forest University, AADA, College of Health Professions, American Academy, Medical school, Private practice, Doctor of Philosophy, FAAD, Government, Pharmacist, Journal, Publication, AAD, Physician, Allergen of the Year, Executive Committee, California Community College Athletic Association, Diagnosis, American Academy of Dermatology, American College of Mohs Surgery, Education, American College, Skin, Pennsylvania Academy of the Fine Arts, Veterinary medicine, Management, Dermatology, MD

He is a past chair of the Academy's Advisory Board and has served on its Board of Directors and its Executive Committee.

Key Points: 
  • He is a past chair of the Academy's Advisory Board and has served on its Board of Directors and its Executive Committee.
  • Each individual listed below will serve a four-year term on the American Academy of Dermatology's Board of Directors.
  • He previously served as president of the Pennsylvania Academy of Dermatology and Dermatologic Surgery, Philadelphia Dermatological Society, and American Contact Dermatitis Society.
  • She served on the Journal of the American Academy of Dermatology Editorial Board and as chair of the AAD's Scientific Assembly Committee.

Terrence A. Cronin Jr., MD, FAAD, assumes presidency of the American Academy of Dermatology

Retrieved on: 
Friday, March 17, 2023
Hair, American Academy of Dermatology, University, Wake Forest University, AADA, American Academy, Private practice, FAAD, Health policy, Government, Medicare, Patient, Physician, Executive Committee, Diagnosis, Skin, Hospital, Dermatology, MD

NEW ORLEANS, March 17, 2023 /PRNewswire/ -- Board-certified dermatologist Terrence A. Cronin Jr., MD, FAAD, will begin his one-year term as president of the American Academy of Dermatology at the close of the Academy's Annual Meeting.

Key Points: 
  • NEW ORLEANS, March 17, 2023 /PRNewswire/ -- Board-certified dermatologist Terrence A. Cronin Jr., MD, FAAD, will begin his one-year term as president of the American Academy of Dermatology at the close of the Academy's Annual Meeting.
  • Dr. Cronin will lead the world's largest dermatologic society that represents more than 20,800 physicians who specialize in diagnosis and treatment of skin, hair, and nail conditions.
  • He will also hold the same position for the American Academy of Dermatology Association, a sister organization focused on government affairs, health policy, and practice information.
  • Dr. Cronin has been involved with the Academy at the leadership level since 2006.

CeraVe Puts Dermatologists on Parade in New Orleans to Reinforce the Importance of Daily SPF with New #21DaysofSPF Challenge

Retrieved on: 
Friday, March 17, 2023
Radiation, Journal of Drugs in Dermatology, WEAR, Habit, UVA, Communication, Dermatology, Lipid, SPF, Hyaluronic acid, Jackson Square, American Academy, OnePoll, FAQ, Science, Name, Journal, UV, French, American Academy of Dermatology, Ceramide, Challenge, L'Oréal, Weather, Skin, Cosmetics

NEW YORK, March 17, 2023 /PRNewswire/ -- CeraVe, the #1 dermatologist-recommended skincare brand in the United States1, hit the streets of New Orleans with some of social media's biggest dermatologists and top content creators like Avani Gregg, to launch the #21DaysofSPF Challenge. According to the American Academy of Dermatology2, exposure to UV rays is the most preventable risk factor when it comes to skin cancer, which is why dermatologists recommend using sunscreen every day. Since it is widely believed that committing for 21 days can help form a new habit, these skin experts and influential voices are joining CeraVe to help consumers make sunscreen application a daily habit for healthier skin.

Key Points: 
  • The New Orleans takeover featured two of the internet's favorite truth-tellers, Dude with Sign and Dudette with Sign , who joined over 50 of social media's most-followed dermatologists for the parade in the French Quarter.
  • Starting at the historic Jackson Square, a float built with larger-than-life components reminded passersby to "WEAR SPF."
  • Along the way, dermatologists strutted the streets with fun signs featuring dermatologist-approved sun-safe skin advice to further amplify the moment.
  • This can be as simple as incorporating CeraVe's moisturizer with broad-spectrum SPF 30 into a skincare routine each morning."

Kyowa Kirin Will Present New Rocatinlimab Phase 2b Data in Atopic Dermatitis at the American Academy of Dermatology Annual Meeting 2023

Retrieved on: 
Friday, March 17, 2023
NRS, Pros, Inflammation, Dermatology Life Quality Index, Week, Chills, Sleep, Fever, American Academy, Atopic dermatitis, Common, MSAD, Pain, Kyowa Kirin, OX40, DLQI, Patient, AAD, Pain scale, Itch, American Academy of Dermatology, Annual general meeting, Nausea, Aphthous stomatitis, Immunoglobulin E, Headache, SD, TSE, Disease, Vaccine, Aluminium, Copper, Silviculture

AD affects 15-20% of children and up to 10% of adults, making it the 15th most common nonfatal disease.

Key Points: 
  • AD affects 15-20% of children and up to 10% of adults, making it the 15th most common nonfatal disease.
  • "We are pleased to share this additional data from the rocatinlimab Phase 2b study," said Yoshifumi Torii, Ph.D., Executive Officer, Vice President, Head of R&D Division of Kyowa Kirin.
  • From baseline to Week 16, percentage reductions in NRS-pruritus (p≤0.029) and NRS-SD scores (p≤0.025) were greater in the rocatinlimab groups compared with placebo.
  • The most frequent TEAEs, reported in ≥ 10% of subjects in the combined rocatinlimab groups were nasopharyngitis, worsening of AD, pyrexia and chills.

Lutris Pharma Presents Data From a Real-World Analysis of Skin Toxicity From EGFR Inhibitors - an Unmet Challenge, at the 2023 American Academy of Dermatology Annual Meeting

Retrieved on: 
Friday, March 17, 2023
Database, Arthritis, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Trinity, IQVIA, Xeroderma, Telangiectasia, Department of Medicine – University of Pamplona, Clinical trial, Medicine, State university system, Cancer, American Academy, Toxicity, Skin condition, Paronychia, Bangladesh Technical Education Board, TEL, Trichomegaly, State University of New York Upstate Medical University, Patient, AAD, EGFR, American Academy of Dermatology, Hyperpigmentation, Human musculoskeletal system, Poster, FDA, Rash, NIH, Skin, Pharmaceutical industry, Lutris

The analysis was supported, in part, by Lutris Pharma and the intramural research program of the National Institutes of Health (NIH).

Key Points: 
  • The analysis was supported, in part, by Lutris Pharma and the intramural research program of the National Institutes of Health (NIH).
  • While such patients are commonly treated prophylactically with antibiotics, there is insufficient evidence to support its practice, leading to a significant unmet medical need."
  • EGFR inhibitors are approved for the treatment of multiple epithelial tumors and can be either biologics or small molecules.
  • The poster will be available after the event on the "Events and Presentations" section of Lutris' website at: https://www.lutris-pharma.com/events-and-presentations/

Lutris Pharma Presents Data From a Real-World Analysis of Skin Toxicity From EGFR Inhibitors - an Unmet Challenge, at the 2023 American Academy of Dermatology Annual Meeting

Retrieved on: 
Friday, March 17, 2023
Database, Arthritis, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Trinity, IQVIA, Xeroderma, Telangiectasia, Department of Medicine – University of Pamplona, Clinical trial, Medicine, State university system, Cancer, American Academy, Toxicity, Skin condition, Paronychia, Bangladesh Technical Education Board, TEL, Trichomegaly, State University of New York Upstate Medical University, Patient, AAD, EGFR, American Academy of Dermatology, Hyperpigmentation, Human musculoskeletal system, Poster, FDA, Rash, NIH, Skin, Pharmaceutical industry, Lutris

The analysis was supported, in part, by Lutris Pharma and the intramural research program of the National Institutes of Health (NIH).

Key Points: 
  • The analysis was supported, in part, by Lutris Pharma and the intramural research program of the National Institutes of Health (NIH).
  • While such patients are commonly treated prophylactically with antibiotics, there is insufficient evidence to support its practice, leading to a significant unmet medical need."
  • EGFR inhibitors are approved for the treatment of multiple epithelial tumors and can be either biologics or small molecules.
  • The poster will be available after the event on the "Events and Presentations" section of Lutris' website at: https://www.lutris-pharma.com/events-and-presentations/

Sensus Healthcare announces the Sensus Cloud™; Unveils New Features at American Academy of Dermatology (AAD) Annual Meeting in New Orleans March 17-19

Retrieved on: 
Thursday, March 16, 2023
Cloud, American Academy of Dermatology, Health, Booth, OpenAI, Record, Dermatology, EMR, AAD, American Academy, Patient, Physician, BOCA, Data collection, AI, Medical imaging

This powerful cloud-based platform offers new innovative features that will revolutionize how healthcare providers monitor treatment progression, manage assets, and safeguard patient data.

Key Points: 
  • This powerful cloud-based platform offers new innovative features that will revolutionize how healthcare providers monitor treatment progression, manage assets, and safeguard patient data.
  • The Sensus Cloud gives dermatologists and aesthetic practitioners unprecedented access to their patients' records, streamlining the care they can provide.
  • Sensus Cloud also includes monitoring features that can alert users when changes are made to their data or assets.
  • Sensus Healthcare will be demonstrating Sensus Cloud at the American Academy of Dermatology (AAD) Annual Meeting in New Orleans on March 17 – 19, 2023.